Skip to content

Effects of low-dose dexmedetomidine on postoperative gastrointestinal function recovery in patients with scoliosis

Effects of low-dose dexmedetomidine on postoperative gastrointestinal function recovery in patients with scoliosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121445
Enrollment
Unknown
Registered
2026-03-31
Start date
2025-07-16
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delayed recovery of gastrointestinal function and postoperative nausea and vomiting

Interventions

DEX Group (Trial Group):Dexmedetomidine: loading dose of 0.5 µg/kg over 15 minutes, followed by maintenance infusion of 0.1 µg/kg/h until 30 minutes before skin closure
saline control group received the same procedure but with normal saline.
Control Group:Normal saline: loading dose of 0.5 µg/kg over 15 minutes, followed by maintenance infusion of 0.1 µg/kg/h until 30 minutes before skin closure (simulated administration procedure).

Sponsors

Drum Tower Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients >10 years old with scoliosis who underwent lumbar long-segment spinal fusion surgery under general anesthesia. 2.ASA is graded as I~III; 3.Pass the ethics review and sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1.Patients with recent or previous gastrointestinal diseases, cardiovascular diseases, respiratory diseases and/or central nervous system diseases, severe liver and kidney dysfunction, mental illness or severe audio-visual dysfunction who cannot cooperate with the study; 2.Patients who are allergic to dexmedetomidine or other anesthetic drugs, or who are preoperatively prescribed antihypertensive drugs containing clonidine or alpha 2-adrenergic receptor agonists. 3.Patients with simple thoracic scoliosis with higher parietal spine (including those undergoing selective thoracic spinal fusion); 4.Preoperative use of opioids, bradycardia (heart rate < 50 beats/min), and cardiac block greater than grade 1;

Design outcomes

Primary

MeasureTime frame
Time to first flatus within 48 hours postoperatively;Time to first defecation within 48 hours postoperatively;Time to first intake of food within 48 hours postoperatively;Incidence of adverse events including nausea, vomiting, and dizziness within 48 hours postoperatively;

Secondary

MeasureTime frame
Serum motilin level before surgery;Serum motilin level at 24 hours postoperatively;

Countries

China

Contacts

Public ContactZhang Wei

Drum Tower Hospital

genine@126.com+86 25 83304616

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026